Ovala, Inc.
PrivateLast Round
Seed Round
Mar 31, 2026
Total Funding Raised
$11.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ovala, Inc. is a medical device company that develops and markets Revive, an FDA-cleared, reusable, over-the-counter bladder support device designed to manage stress urinary incontinence in women.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, E-commerce, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ovala, Inc. Comparables
Compare Ovala, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Minerva Health Solutions Inc. | 93% | |
| Uresta | 90% | |
| Cntrl+ Inc. | 88% | |
Ovala, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 31, 2026 | ||||
| Series B | Dec 1, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Raised $3.3M in seed funding.
- Dec 1, 2024
$3M round completed.
Ovala, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ovala, Inc.'s valuation, stock price, and market status.